4//SEC Filing
Kallenbach Charles 4
Accession 0000899243-20-017277
CIK 0001412408other
Filed
Jun 18, 8:00 PM ET
Accepted
Jun 19, 5:06 PM ET
Size
9.6 KB
Accession
0000899243-20-017277
Insider Transaction Report
Form 4
Kallenbach Charles
General Counsel & Secretary
Transactions
- Exercise/Conversion
Common Stock
2020-06-17$2.55/sh+2,500$6,375→ 41,650 total - Exercise/Conversion
Stock Option (Right to Buy)
2020-06-17−2,500→ 146,785 totalExercise: $2.55Exp: 2026-10-16→ Common Stock (2,500 underlying) - Sale
Common Stock
2020-06-17$29.26/sh−2,500$73,145→ 39,150 total
Footnotes (4)
- [F1]This transaction was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]A portion of these shares represent Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $28.91 to $29.48 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]25% of this option vested and became exercisable on October 17, 2017, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
Documents
Issuer
Phreesia, Inc.
CIK 0001412408
Entity typeother
Related Parties
1- filerCIK 0001309021
Filing Metadata
- Form type
- 4
- Filed
- Jun 18, 8:00 PM ET
- Accepted
- Jun 19, 5:06 PM ET
- Size
- 9.6 KB